Skip to main content
Equibles
PRCT logo

PRCT · PROCEPT BioRobotics Corp

Track PRCT — free

Use PRCT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$21.37 -0.60 (-2.73%) At close · Sep 3
Russell 2000 member Rebalance outlook locked
Market Cap
$1.20B
Shares
57.27M

PRCT metrics

68 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$21.97
Market cap
$1.20B

Price action

19 metrics
Price change (1W)
+4.3%
Price change (30D)
+20.2%
Price change (3M)
-16.6%
Price change (6M)
-17.3%
Price change (YTD)
-30.2%
Price change (1Y)
-44.5%
Trailing year
Price change (5Y)
—
52-week high
$40.68
52-week low
$16.69
Change from 52-week high
-46.0%
Change from 52-week low
+31.6%
Annualized volatility
63.2%
Beta
0.8
RSI (14D)
56.8
Price vs SMA 50
+8.0%
Price vs SMA 200
-15.8%
Avg volume (3M)
1.57M
Relative volume
0.8
Average dollar volume
$33.19M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
57.27M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.6×
reciprocal yield 28.2%
P / book
3.5
reciprocal yield 28.4%
FCF yield
-7.1%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
11.3×
reciprocal yield 8.9%
EV / revenue historical average (5Y)
14.3×
reciprocal yield 7.0%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-04

Profitability

9 metrics
Gross margin
64.2%
Operating margin
-33.9%
Trailing 12 months
Net margin
-32.5%
Gross profit (TTM)
$216.65M
Operating profit (TTM)
−$114.23M
Net income (TTM)
−$109.76M
Trailing 12 months
Diluted EPS (TTM)
$-1.95
FCF margin
-25.2%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-38.81

Growth

11 metrics
Revenue growth YoY
+19.3%
Year over year
Net income growth YoY
—
Revenue (TTM)
$337.34M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.9%
Year over year · more shares
Revenue CAGR (3Y)
+60.1%
Revenue CAGR (5Y)
+109.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-32.3%
Return on assets
-22.9%
Debt / equity
—
Current ratio
6.5
EBITDA (TTM)
−$107.18M
Free cash flow (TTM)
−$84.92M
Quick ratio
5.3
Interest coverage
-32.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$227.91M
Total assets
$479.35M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$74.34M
Capital expenditures (TTM)
$10.59M
R&D (TTM)
$78.81M
SG&A (TTM)
$252.06M
Stock compensation (TTM)
$52.94M
R&D / revenue
23.4%
Stock compensation / revenue
15.7%

Ownership (13F)

3 metrics
13F filers
257
13F filer change QoQ
-2
Institutional ownership
97.1%

Short interest

3 metrics
Short interest
13.5%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
$469,836
Insider-sentiment score
66 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1588978 CUSIP 74276L105 13F (30d) 192 filings 191 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)